Ovarian Cancer: Selecting an Appropriate PARP Inhibitor | OncLive
Ovarian Cancer: Selecting an Appropriate PARP Inhibitor | OncL…
Nov 20, 2017
onclive.com
Management of PARP Inhibitor AEs in Ovarian Cancer | OncLive
Management of PARP Inhibitor AEs in Ovarian Cancer | OncLive
Apr 29, 2019
onclive.com
PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients | Cancer | Women's Health | UT Southwestern Medical Center
PARP-1 inhibitors can reduce ovarian cancer recurrence risk by …
Sep 16, 2021
utswmed.org
Got questions about PARP inhibitors? If you’ve been diagnosed with stage 3 or 4 high grade epithelial ovarian cancer, you may be able to access PARP inhibitors after you’ve finished chemotherapy. Find out about the options that may be available to you using our PARP inhibitor tool 👉 https://bit.ly/3qk1paZ Used the tool and found it helpful? Let us know 👇 | Target Ovarian Cancer
0:09
Got questions about PARP inhibitors? If you’ve been diagnos…
2K viewsJun 22, 2024
FacebookTarget Ovarian Cancer
Next-Generation PARP1-Selective Inhibitor Offers Significant Benefits Over Older Predecessors in Treatment of Solid Tumors
Next-Generation PARP1-Selective Inhibitor Offers Significant Benefit…
May 25, 2022
ascopost.com
New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibitor Olaparib Approved By The FDA
New Hope For Later Stage Prostate Cancer Patients: The PARP Inhibit…
May 21, 2020
survivornet.com
Role of PARP Inhibition and I/O Therapy in TNBC | OncLive
Role of PARP Inhibition and I/O Therapy in TNBC | OncLive
Apr 22, 2020
onclive.com
Dr. Yardley on the FDA Approval of Talazoparib in Breast Cancer | On…
Oct 16, 2018
onclive.com
Dr. Hassan on the Rationale for Examining Talazoparib Plus Carbo…
Apr 14, 2021
onclive.com
Dr Vidula on the Evaluation of Talazoparib in BRCA1/2-Mutated …
Jun 19, 2023
onclive.com
Dr Vaishampayan on the Use of Talazoparib and Enzalutamide in P…
Aug 24, 2023
onclive.com
The Mechanism of Action of Olaparib | Targeted Oncology - Im…
Jul 30, 2013
targetedonc.com
Duration of PARP Inhibitor Maintenance Therapy for Ovarian …
Oct 7, 2024
onclive.com
6:35
PARP Inhibitor Side Effect Management in Ovarian Cancer
3.5K viewsJan 23, 2018
YouTubeOncLive
3:05
An Overview of PARP Inhibitors in Ovarian Cancer
4.1K viewsJun 25, 2020
YouTubeTargeted Oncology
5:05
Anti-HER2 Mechanisms of Approved HER2 Inhibitors
165.9K viewsApr 30, 2013
YouTubeHMP Education
12:24
The Role of Targeting DNA Repair with PARP
6.9K viewsApr 3, 2018
YouTubeGrand Rounds in Urology
2:47
What is a PARP Inhibitor? | Dana-Farber Cancer Institute | Science Il…
89.2K viewsNov 17, 2016
YouTubeDana-Farber Cancer Institute
5:15
Rucaparib and Olaparib: Two New Treatments Approved for Advance…
4K viewsJun 2, 2020
YouTubeProstate Cancer Research Institute
3:12
PARP-inhibitors: A New Generation of Cancer Drugs
73.9K viewsDec 24, 2014
YouTubeCambridge University
1:26
PARP Inhibitors for Maintenance Therapy in Ovarian Cancer
3.4K viewsOct 23, 2019
YouTubeCleveland Clinic
4:12
PARP Inhibitors
4.1K viewsSep 11, 2017
YouTubeMayo Clinic
11:22
Olaparib in Ovarian Cancer
4K viewsJul 17, 2015
YouTubeOncLive
2:45
About Ovarian Cancer Treatment Lynparza
6.1K viewsMay 26, 2015
YouTubeOncology Associates
1:20
How to pronounce olaparib
2.9K viewsAug 12, 2021
YouTubeBiomedical Pronunciation Guide
1:41
How to pronounce rucaparib
265 viewsAug 18, 2021
YouTubeBiomedical Pronunciation Guide
5:18
Rucaparib for Ovarian Cancer
3.2K viewsFeb 20, 2017
YouTubeOncLive
10:36
PARP Inhibitor Trial Updates
232 viewsAug 9, 2019
YouTubeOncLive
18:28
PARP Inhibitors: 2023 Updates
1.2K viewsJan 29, 2024
YouTubeOCRA
3:42
PARP + Maintenance Bevacizumab in Ovarian Cancer
1K viewsMay 17, 2019
YouTubeOncLive
See more videos
Static thumbnail place holder